Purchase this article with an account.
Jasbeth Ledesma Gil, Karla Olivia Van-Dick Sánchez, Enrique O Graue-Hernandez, Alejandro Navas; Supraciliary micro-stent device for glaucoma after keratoplasty. Invest. Ophthalmol. Vis. Sci. 2018;59(9):2054.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
To report the outcomes of patients with secondary glaucoma after keratoplasty treated with the implantation of suprachoroidal micro-stent.
Prospective study of consecutive clinical cases who underwent Cypass Micro-Stent (Alcon Laboratories, Inc.) as standalone procedure for the treatment of glaucoma due to keratoplasty. Microstenting via an ab interno approach to the supraciliary space were performed in all cases. STATA 8.0 and SPSS software were used for statistical analysis.
Six eyes of six patients with a mean age of 33.83 (±17.26). A total of 83.33% were male and 16.66% were female. 5 cases after penetrating keratoplasty and 1 following deep anterior lamellar keratoplasty, 5 cases were phakic and 1 pseudophakic. Mean preoperative intraocular pressure was 28.83 (±17.26) mmHg with maximal medical therapy decreasing to a mean postoperatively to 13.33 (±6.30) mmHg [P=0.001]. Mean follow-up was 3 (±1.15) months. Visual acuity preoperatively was 1.23 (±0.91) logMAR and posoperatively 0.98 (±0.79).
Supraciliary micro-stent could be an alternative in the management of secondary glaucoma after following keratoplasty. Further follow-up and comparative studies are needed to evaluate efficacy and safety of these novel devices in patients with glaucoma after keratoplasty.
This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.
This PDF is available to Subscribers Only